Zhang, Z., Guan, M., Li, N., Qiu, W., Ba, Y., Yao, G., Guo, Y. (2026). A phase II trial evaluating liposomal irinotecan combined with capecitabine as second-line therapy for biliary tract cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16261